Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hellenic Journal of Cardiology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 22484777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Increased Heart Rate on Clinical Outcomes in Hypertension

  2012cited by this paper
• Stable coronary artery disease: latest data in the battle between conservative and invasive management.

  2011cited by this paper
• Chronic stable angina: percutaneous coronary intervention or medication?

  2011cited by this paper
• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

  2011cited by this paper
• Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study Cohort

  2010cited by this paper
• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.

  2010cited by this paper
• Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey

  2010cited by this paper
• Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

  2009cited by this paper
• Prevalence and five-year incidence (2001-2006) of cardiovascular disease risk factors in a Greek sample: the ATTICA study.

  2009cited by this paper
• Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

  2009cited by this paper
• Meta-analysis: -Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

  2009cited by this paper
• Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms.

  2008cited by this paper
• Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

  2008influential reference
• The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population

  2007influential reference
• Resting heart rate in cardiovascular disease.

  2007cited by this paper
• Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.

  2007cited by this paper
• Coronary heart disease Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction : a meta-regression of randomized clinical trials

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study.

  2007cited by this paper
• QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up

  2006cited by this paper
• Predicting prognosis in stable angina—results from the Euro heart survey of stable angina: prospective observational study

  2006cited by this paper
• Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

  2006influential reference
• Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

  2005cited by this paper
• Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.

  2005influential reference
• Prevalence of COPD in Greece.

  2004cited by this paper
• Elevated Heart Rate: A Major Risk Factor for Cardiovascular Disease

  2004cited by this paper
• Prognostic benefits of heart rate reduction in cardiovascular disease

  2003cited by this paper
• Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.

  2003cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).

  2003cited by this paper
• Contributions of heart rate and contractility to myocardial oxygen balance during exercise.

  2003cited by this paper
• Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma.

  2001cited by this paper
• Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.

  2000influential reference
• Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma?

  2000cited by this paper
• Changes in rates of β-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction

  2000cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• High heart rate: a risk factor for cardiovascular death in elderly men.

  1999influential reference
• beta Blockade after myocardial infarction: systematic review and meta regression analysis.

  1999cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• Impact of Diabetes on Mortality After the First Myocardial Infarction

  1998cited by this paper
• Heart rate as marker of sympathetic activity

  1998cited by this paper
• Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.

  1997influential reference
• Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction

  1997cited by this paper
• Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.

  1997cited by this paper
• Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.

  1996cited by this paper
• Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

  1996cited by this paper
• Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation.

  1994cited by this paper
• Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study.

  1991cited by this paper
• Pathophysiology of angina.

  1990cited by this paper
• Sympathetic nervous system and cardiac arrhythmias

  1990cited by this paper
• Cardiac Electrophysiology: From Cell to Bedside

  1990cited by this paper
• Heart rate and cardiovascular mortality: the Framingham Study.

  1987cited by this paper

• Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease

  2017cites this paper
• Predictive Models of Quality of Life from Biometric Sensors

  2017cites this paper
• The Role of Ivabradine in the Management of Angina Pectoris

  2016cites this paper
• Caracterization of patients with Chronic Obstructive Pulmonary Disease under non- invasive mechanical ventilation treatment

  2015cites this paper
• Caracterización de pacientes con Enfermedad Pulmonar Obstructiva Crónica bajo tratamiento con ventilación mecánica no invasiva

  2015cites this paper
• Beta-blockers in patients with chronic obstructive disease and coexistent cardiac illnesses

  2015cites this paper
• Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies

  2014cites this paper
• The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit

  2014cites this paper
• Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Cardiovascular Links

  2014cites this paper
• Medical management of stable angina.

  2014cites this paper
• Is there a role for ivabradine beyond its conventional use?

  2014cites this paper
• Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome

  2014cites this paper
• Effects of smoking on heart rate at rest and during exercise, and on heart rate recovery, in young adults.

  2013cites this paper
• [LINKOR: results of observational program in patients with myocardial infarction].

  2013cites this paper
• Design of Pervasive Rehabilitation Monitoring for Chronic Obstructive Pulmonary Disease

  2013cites this paper